Clinical Trial Update: Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial is evaluating Zipalertinib in combination with carboplatin and pemetrexed for patients with resectable stage II-IIIB non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pemetrexed (pemetrexed)
• Zipalertinib (Zipalertinib)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lung Non-Squamous Non-Small Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING